In addition, it was demonstrated that hemin- (inducer of HO-1) treated mice also had reduced VEGF levels and were protected against ARDS, defending the alveolar capillary barrier in vitro [15]. This evidence concerns the gene HMOX1 and acute respiratory distress syndrome.